Related Experiment Video
Updated: May 22, 2026

Three Strategies to Induce Neurotrophic Keratitis and Nerve Regeneration in Murine Cornea
Published on: December 8, 2023
Nerve growth factor therapy for corneal disease
Alessandro Lambiase1, Marta Sacchetti, Stefano Bonini
1Department of Ophthalmology, University of Rome Campus Bio-Medico, Via Alvarodel Portillo 200, Rome, Italy. a.lambiase@unicampus.it
Nerve growth factor (NGF) demonstrates significant therapeutic potential for various corneal diseases by supporting ocular surface healing and modulating immune responses. Future development of NGF therapy promises new treatments for infective and noninfective ocular surface conditions.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Neuroscience
Background:
- Nerve Growth Factor (NGF) is crucial for ocular surface health, influencing immune reactions, trophic support, and corneal sensitivity.
- Dysfunction in these processes contributes to various corneal pathologies.
Purpose of the Study:
- To comprehensively review experimental and clinical data on NGF's role in corneal physiopathology.
- To explore the therapeutic potential and future development of NGF for corneal diseases.
Main Methods:
- Systematic review of experimental studies on NGF mechanisms on the ocular surface.
- Analysis of clinical data from topical NGF applications in human subjects.
- Inclusion of studies on neurotrophic keratitis, dry eye, and corneal surgery.
Main Results:
- NGF is vital for ocular surface healing, immune modulation, corneal sensitivity, and tear film stability.
- Topical NGF has shown promise in treating conditions like neurotrophic keratitis and dry eye.
- Experimental data suggests NGF's role in managing herpes virus infections and promoting ocular surface stem cell functions.
Conclusions:
- NGF's ocular surface healing and immune-modulating effects are well-established, supporting its therapeutic use.
- Two decades of research highlight NGF's potential for treating a range of infective and noninfective ocular surface diseases.
- Continued research and clinical application of NGF therapy are opening new avenues for treating corneal conditions.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

